Rizonib 250mg Crizotinib
Description
Rizonib 250mg crizotinib is a targeted therapy that blocks the growth of cancer cells in metastatic non-small cell lung cancer (NSCLC).
Rizonib 250mg crizotinib is a targeted therapy that blocks the growth of cancer cells in metastatic non-small cell lung cancer (NSCLC).
Reviews
There are no reviews yet.